Showing results (31-40 of 3,346) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|December 5, 2024
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Differences Analyses Using the UK Household Longitudinal SurveyBecky Pennington, Mónica Hernández Alava, Mark StrongPharmacoeconomics|December 4, 2024
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast CancerTrang T H Nguyen, Shweta MitalPharmacoeconomics|November 2, 2024
Measuring Effectiveness Based on Patient Experience (Instead of QALYs) in US Value AssessmentsMaksat Jumamyradov, Benjamin M CraigPharmacoeconomics|November 3, 2024
A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in OncologySietse van Mossel, Rafael Emilio de Feria Cardet, Lioe-Fee de Geus-Oei, et al.Pharmacoeconomics|November 17, 2025
A Systematic Review of Decision-Analytic Modelling Approaches in Economic Evaluations of Post-traumatic Stress Disorder TreatmentsSheradyn R Matthews, Laura C Edney, Reginald D V NixonPharmacoeconomics|October 14, 2025
Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?Dan Jackson, Michael Sweeting, Robert Hettle, et al.Pharmacoeconomics|December 19, 2019
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data MaturityTim S Grant, Darren Burns, Christopher Kiff, et al.Pharmacoeconomics|September 22, 2020
Recalibrating Health Technology Assessment Methods for Cell and Gene TherapiesAris Angelis, Huseyin Naci, Allan HackshawPharmacoeconomics|July 12, 2021
Valuing SF-6Dv2 in Australia Using an International ProtocolBrendan Mulhern, Richard Norman, John BrazierPharmacoeconomics|July 29, 2021
The Challenges of Measuring Informal Care Time: A Review of the LiteratureSean Urwin, Yiu-Shing Lau, Gunn Grande, et al.Pageof 335